GlassScriptPhysician profile
Showkat Haji
NPI 1801099775
$1,505.89
in general payments reported to CMS, 2019-2025
19 companies · $90.64 in 2025
The $90.64 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $438 · 2020: $103 · 2021: $112 · 2022: $172 · 2023: $285 · 2024: $305 · 2025: $90.64.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $681.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $680.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $259.68 | 2019-2025 | Eliquis, Camzyos |
| Boston Scientific Corporation | $159.06 | 2021-2025 | Lux-Dx Insertable Cardiac Monitor, Truselect |
| Abiomed | $144.56 | 2019-2021 | |
| Pfizer INC. | $141.41 | 2019-2022 | |
| Medtronic Vascular, INC. | $138.53 | 2019-2020 | |
| Baxter Healthcare | $135.49 | 2022-2025 | Hillrom - Cardiac Ambulatory Monitor |
| Sk Life Science, INC. | $104.73 | 2023-2024 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $97.17 | 2020-2025 | Lifevest |
| Elutia, INC. | $87.90 | 2019 | |
| Alexion Pharmaceuticals, INC. | $45.01 | 2023-2024 | Soliris |
| Medtronic, INC. | $42.59 | 2022-2023 | Onyx 18 |
| Ucb, INC. | $30.59 | 2023 | |
| Argenx US, INC. | $21.81 | 2024 | Vyvgart Hytrulo |
| Cook Medical LLC | $18.90 | 2020 | |
| Astrazeneca Pharmaceuticals LP | $18.24 | 2019 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neurelis, INC. | $17.47 | 2024 | Valtoco |
| Janssen Pharmaceuticals, INC | $15.84 | 2022 | |
| Bardy Diagnostics, INC. | $15.00 | 2022 | |
| Amgen INC. | $11.91 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Showkat Haji listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.